Mingyue Optical Lens Hits Day Low Amid Price Pressure, Now at CNY 31.71

Mingyue Optical Lens Co., a mid-cap player in the Pharmaceuticals & Biotechnology sector, experienced a notable decline today, with its stock price dropping by 5.44% on March 23, 2026. The stock reached an intraday low of CNY 31.71, reflecting ongoing challenges in its performance metrics. Over the past week, Mingyue has seen a decrease of 10.52%, and its one-month performance shows a significant drop of 20.76%. Year-to-date, the stock has declined by 22.81%, contrasting sharply with the China Shanghai Composite, which has only fallen by 3.92% during the same period. In terms of financial health, the company has reported a return on equity of 10.48% and a price-to-earnings ratio of 49.00. Despite a high dividend yield of 0.46%, the stock's performance over the last year has been underwhelming, with a return of -41.26%. The company's net sales have grown at an annual rate of 9.45% over the last five years, but this growth has not translated into strong stock performance, indicating potential concerns for stakeholders.